Recent Finacing
Recent Raise
Avisa Pharma develops a breath-based diagnostic that detects urease-expressing lung pathogens by administering inhaled 13C-urea and measuring produced 13CO2 with a spectrophotometer for rapid, whole-lung detection.
Focus Areas
Total Raised
Funding rounds